Role of the standardized uptake value of 18-fluorodeoxyglucose positron emission tomography-computed tomography in detecting the primary tumor and lymph node metastasis in colorectal cancers

Surgery Today

Volumn 42, Issue 10, 2012, Pages 956-961

  Uchiyama, Shuichiro ^a   Haruyama, Yukihiro ^a   Asada, Takashi ^a   Hotokezaka, Masayuki ^a   Nagamachi, Shigeki ^a   Chijiiwa, Kazuo ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Colorectal cancer; Lymph node metastasis; MD CT; PET CT; SUV

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IOPAMIDOL;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CLINICAL FEATURE; COLORECTAL CANCER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PARAMETERS; PRIMARY TUMOR; SENSITIVITY AND SPECIFICITY; STANDARDIZED UPTAKE VALUE; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TUMOR BURDEN;

EID: 84867994197     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-012-0225-6     Document Type: Article

References (19)

1. Shin S, Jeong Y, Min J, Kim H, Chung T, Kang H. Preoperative staging of colorectal cancer: CT vs. integrated FDG PET/CT. Abdom Imaging. 2008;33:270-7. (Pubitemid 351537885)
2. Furukawa H, Ikuma H, Seki A, Yokoe K, Yuen S, Aramaki T, et al. Positron emission tomography scanning is not superior to whole body multidetector helical computed tomography in the preoperative staging of colorectal cancer. Gut. 2006;55:1007-11. (Pubitemid 43962614)
3. Blodgett T, Meltzer C, Townsend D. PET/CT: form and function. Radiology. 2007;242:360-85. (Pubitemid 46150968)
4. Tomikawa M, Korenaga D, Akahoshi T, Kohshi K, Sugimachi K, Ikeda Y, et al. Trends in the treatment outcomes for advanced colorectal cancer: an analysis at a single community hospital in Japan. Surg Today. 2011;41:801-5.
5. Chessin D, Kiran R, Akhurst T, Guillem J. The emerging role of 18F-fluorodeoxyglucose positron emission tomography in the management of primary and recurrent rectal cancer. J Am Coll Surg. 2005;201:948-56. (Pubitemid 41689326)
6. Abdel-Nabi H, Doerr R, Lamonica D, Cronin V, Galantowicz P, Carbone G, et al. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology. 1998;206: 755-60. (Pubitemid 28128526)
7. Cohade C, Osman M, Leal J, Wahl R. Direct comparison of 18FFDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med. 2003;44:1797-803. (Pubitemid 39663312)
8. Park I, Kim H, Yu C, Ryu M, Chang H, Kim J, et al. Efficacy of PET/CT in the accurate evaluation of primary colorectal carcinoma. Eur J Surg Oncol. 2006;32:941-7. (Pubitemid 44739687)
9. Selzner M, Hany T, Wildbrett P, McCormack L, Kadry Z, Clavien P. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 2004;240:1027-34 (discussion 35-6).
10. Llamas-Elvira J, Rodríguez-Fernández A, Gutiérrez-Sáinz J, Gomez-Rio M, Bellon-Guardia M, Ramos-Font C, et al. Fluorine- 18 fluorodeoxyglucose PET in the preoperative staging of colorectal cancer. Eur J Nucl Med Mol Imaging. 2007;34:859-67. (Pubitemid 46798947)
11. Davey K, Heriot A, Mackay J, Drummond E, Hogg A, Ngan S, et al. The impact of 18-fluorodeoxyglucose positron emission tomography-computed tomography on the staging and management of primary rectal cancer. Dis Colon Rectum. 2008;51: 997-1003.
12. Nagata K, Ota Y, Okawa T, Endo S, Kudo S. PET/CT colonography for the preoperative evaluation of the colon proximal to the obstructive colorectal cancer. Dis Colon Rectum. 2008;51: 882-90.
13. Agress HJ, Cooper B. Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET: histopathologic comparison. Radiology. 2004;230:417-22. (Pubitemid 38133801)
14. Filippone A, Ambrosini R, Fuschi M, Marinelli T, Genovesi D, Bonomo L. Preoperative T and N staging of colorectal cancer: accuracy of contrast-enhanced multi-detector row CT colonography - initial experience. Radiology. 2004;231:83-90. (Pubitemid 38375414)
15. Kulinna C, Eibel R, Matzek W, Bonel H, Aust D, Strauss T, et al. Staging of rectal cancer: diagnostic potential of multiplanar reconstructions with MDCT. AJR Am J Roentgenol. 2004;183: 421-7. (Pubitemid 38970336)
16. Tsunoda Y, Ito M, Fujii H, Kuwano H, Saito N. Preoperative diagnosis of lymph node metastases of colorectal cancer by FDGPET/CT. Jpn J Clin Oncol. 2008;38:347-53. (Pubitemid 351753566)
17. Svrcek M, Cosnes J, Beaugerie L, Parc R, Bennis M, Tiret E, et al. Colorectal neoplasia in Crohn's colitis: a retrospective comparative study with ulcerative colitis. Histopathology. 2007;50:574-83. (Pubitemid 46495833)
18. Green J, Timmcke A, Mitchell W, Hicks T, Gathright JJ, Ray J. Mucinous carcinoma - just another colon cancer? Dis Colon Rectum. 1993;36:49-54. (Pubitemid 23019444)
19. Berger K, Nicholson S, Dehdashti F, Siegel B. FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features. AJR Am J Roentgenol. 2000;174: 1005-8. (Pubitemid 30179992)